Sustained-Release Devices for the Treatment of Chronic Eye Diseases

Traditional topical drug delivery for the treatment of ocular diseases has a number of challenges including compliance; tearing and blinking, which results in medication spillage and drug dilution; tear film turnover; and inadequate absorption. In addition, medication noncompliance and loss to follow-up are additional common problems, especially for patients with with chronic diseases like age-related macular degeneration, diabetic macular edema and glaucoma. To combat these challenges to t...
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 2

It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious. The target audience for this CE Activity is Optometrists. Learning Objectives This educational activi...
Evolve Medical Education LLC

Navigating the World of Retina: Updates for the Newer Retina Specialist

Retinal disorders, including age-related macular degeneration (AMD) and diabetic macular edema (DME), can result in vision loss if not treated early and—in most cases—continuously. The need for newer retina specialists to be fully educated on the various treatment options remains crucial to delivering the best patient care. In addition, retina specialists new to practice must also navigate the business aspects of their clinics. TARGET AUDIENCE This certified CME activity is designed fo...
Evolve Medical Education LLC

Optimizing Patient Outcomes in Diabetic Retinopathy

Target Audience Content and educational strategies have been designed to facilitate behavior change in ophthalmologists, primary care physicians, residents and fellows, physician assistants, nurse practitioners, optomistrists, and all health care providers (HCPs) who care for patients at risk for diabetes and associated retinal disease. Learning Objectives Upon completion of this activity, participants should be able to: Identify and compare current treatment pathways for diabetic ...

Cases in Prevention: Where the Latest Research on Diabetic Retinopathy Meets the Real World

Program Overview Diabetic retinopathy can now be treated earlier to prevent vision-threatening complications. This activity reviews the latest data and strategies. Learning Objectives Upon completion of this activity, participants should be able to: 1. Evaluate the evidence supporting treatment for preventing vision-threatening outcomes in diabetic retinopathy 2. Design treatment plans for diabetic retinopathy that consider individual patient factors 3. Describe clinical trial data s...
Jointly provided by Wills Eye Hospital and MedEdicus LLC

Diabetic Macular Edema Management

Diabetes is the leading cause of new cases of blindness among adults age 18 to 64 years, according to the Centers for Disease Control and Prevention’s 2020 National Diabetes Statistics Report. This activity reviews the management of patients with diabetic macular edema, with a focus on 1- and 2-year results of the Protocol T clinical trial.
Evolve Medical Education LLC

Fundamentals of DR/DME

In the following online activity you will learn about the fundamental trials and treatments on diabetic retinopathy and diabetic macular edema, plus two case presentations from experts in the field of retina. PRIMARY AUDIENCE: Retina specialists involved in the treatment and management of patients with retina disorders.
Evolve Medical Education LLC

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.